Approvals come as the CDC's vaccine advisory panel remains in legal limbo
— Approvals come as the CDC's vaccine advisory panel remains in legal limbo
August 28, 2026
• 2 min read
The FDA approved four updated COVID-19 vaccines for the 2026-2027 season targeting the SARS-C0V-2 variant that dominated last season.
Moderna, Pfizer and BioNTech, and Novavax, Sanofi, and Takeda announced Thursday that their COVID shots formulated against the XFG variant for the upcoming season had earned FDA approval.
QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax - Moderna (NASDAQ:MRNA)
FDA approves latest round of COVID-19 shots
The FDA Just Approved New COVID Shots. Here’s What Happens Now.
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
New COVID Shots Are Coming This Fall. Here’s Who Can Get One.
The FDA just approved this year’s Covid vaccines - here’s what you need to know
FDA approves updated Covid-19 vaccines | CNN
FDA approves updated COVID vaccines. Here's what you need to know
FDA approves latest version of Pfizer's COVID-19 mRNA vaccine - UPI.com
FDA approves new COVID-19 vaccine for seniors
